European Union -
English -
EMA (European Medicines Agency)
lacosamide ucb
ucb pharma s.a. - lacosamide - epilepsies, partial - antiepileptics, - lacosamide ucb is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.,
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
xyrem 500mgml oral solution
ucb pharma ltd - sodium oxybate - oral solution - 500mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nootropil 800mg tablets
ucb pharma ltd - piracetam - oral tablet - 800mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nootropil 1200mg tablets
ucb pharma ltd - piracetam - oral tablet - 1.2gram
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
zirtek allergy 1mg/ml oral solution
ucb pharma ltd - cetirizine hydrochloride - oral solution - 1mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
zirtek allergy relief for children 1mg/ml oral solution
ucb pharma ltd - cetirizine hydrochloride - oral solution - 1mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
xyzal 0.5mg/ml oral solution
ucb pharma ltd - levocetirizine dihydrochloride - oral solution - 500microgram/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nootropil 33% oral solution
ucb pharma ltd - piracetam - oral solution - 333.3mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
briviact 10mg tablets
ucb pharma ltd - brivaracetam - tablet - 10mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
briviact 25mg tablets
ucb pharma ltd - brivaracetam - tablet - 25mg